Literature DB >> 26770495

Association of acylation-stimulating protein and receptor gene polymorphisms with coronary heart disease in Han and Hui populations.

Honglei Jiang1, Xiangju Liu2, Dong Wang3, Fang Guo1, Jidong Liu1, Xiaotang Liang1, Zhaoqin Xing1, Chunlin Cao1.   

Abstract

OBJECTIVE: This study was to analyze the acylation-stimulating protein (ASP) (301T>C) and C5a-like receptor 2 (C5L2) (698C>T) gene polymorphisms in Han and Hui populations, and investigate their association with coronary heart disease (CHD).
METHODS: 245 Han CHD patients and 110 Hui CHD patients from Shandong, Jinan, China were included in this study. Biochemical analysis was performed to assess the blood sugar and lipid levels in these patients, and the TaqMan genotyping assay was used to determine the genotype distribution.
RESULTS: Our results showed that the C allele frequency in the ASP (301T>C) polymorphism in the Hui population was significantly higher than normal controls, while no significant differences were observed in the Han population, which might contribute to the genetic susceptibility of CHD in the Hui population. Moreover, for C5L2 (698C>T) gene polymorphism in both Han and Hui populations, the frequencies of the C/T genotype and T allele were significantly higher in the CHD patients compared with normal controls. Moreover, there were slight differences in the association of ASP and C5L2 gene polymorphisms with blood sugar and lipid levels between Han and Hui populations.
CONCLUSIONS: Our results suggest differential ASP and C5L2 genotype distributions between Han and Hui patients, which might be associated with the different CHD-related genetic susceptibilities in these populations. These findings might contribute to a better understanding of the etiology and pathogenesis of CHD in different regions and populations.

Entities:  

Keywords:  Acylation-stimulating protein (ASP); C5a-like receptor 2 (C5L2); coronary heart disease; gene polymorphism

Year:  2015        PMID: 26770495      PMCID: PMC4694395     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  19 in total

1.  Identification of a novel C5L2 variant (S323I) in a French Canadian family with familial combined hyperlipemia.

Authors:  Michel Marcil; Hai Vu; Wei Cui; Zari Dastani; James C Engert; Daniel Gaudet; Manuel Castro-Cabezas; Allan D Sniderman; Jacques Genest; Katherine Cianflone
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-04-20       Impact factor: 8.311

2.  Cardiovascular and metabolic risk profile and acylation-stimulating protein levels in children with Prader-Willi syndrome and effects of growth hormone treatment.

Authors:  Roderick F A de Lind van Wijngaarden; Katherine Cianflone; Y Gao; Ralph W J Leunissen; Anita C S Hokken-Koelega
Journal:  J Clin Endocrinol Metab       Date:  2010-02-19       Impact factor: 5.958

Review 3.  Diabetes in Asia: epidemiology, risk factors, and pathophysiology.

Authors:  Juliana C N Chan; Vasanti Malik; Weiping Jia; Takashi Kadowaki; Chittaranjan S Yajnik; Kun-Ho Yoon; Frank B Hu
Journal:  JAMA       Date:  2009-05-27       Impact factor: 56.272

Review 4.  Novel roles for acylation stimulating protein/C3adesArg: a review of recent in vitro and in vivo evidence.

Authors:  Magdalena Maslowska; Hong Wei Wang; Katherine Cianflone
Journal:  Vitam Horm       Date:  2005       Impact factor: 3.421

5.  Purification and characterization of acylation stimulating protein.

Authors:  K M Cianflone; A D Sniderman; M J Walsh; H T Vu; J Gagnon; M A Rodriguez
Journal:  J Biol Chem       Date:  1989-01-05       Impact factor: 5.157

6.  Monocyte chemoattractant protein-1 (MCP-1) 2518G/A gene polymorphism in Turkish type 2 diabetes patients with nephropathy.

Authors:  M Karadeniz; M Erdogan; Sevki Cetinkalp; A Berdeli; Z Eroglu; A G Ozgen
Journal:  Endocrine       Date:  2010-04-21       Impact factor: 3.633

7.  Lipoprotein lipase deficiency is associated with elevated acylation stimulating protein plasma levels.

Authors:  Sabina Paglialunga; Pierre Julien; Youssef Tahiri; Francois Cadelis; Jean Bergeron; Daniel Gaudet; Katherine Cianflone
Journal:  J Lipid Res       Date:  2009-02-23       Impact factor: 5.922

8.  Effect of acylation stimulating protein on the triacylglycerol synthetic pathway of human adipose tissue.

Authors:  Z Yasruel; K Cianflone; A D Sniderman; M Rosenbloom; M Walsh; M A Rodriguez
Journal:  Lipids       Date:  1991-07       Impact factor: 1.880

9.  The chemoattractant receptor-like protein C5L2 binds the C3a des-Arg77/acylation-stimulating protein.

Authors:  David Kalant; Stuart A Cain; Magdalena Maslowska; Allan D Sniderman; Katherine Cianflone; Peter N Monk
Journal:  J Biol Chem       Date:  2003-01-22       Impact factor: 5.157

10.  Inflammation and dyslipidaemia: a possible interplay between established risk factors in North Indian males with coronary artery disease.

Authors:  B Goswami; M Rajappa; B Singh; P C Ray; S Kumar; V Mallika
Journal:  Cardiovasc J Afr       Date:  2010 Mar-Apr       Impact factor: 1.167

View more
  2 in total

Review 1.  The Controversial C5a Receptor C5aR2: Its Role in Health and Disease.

Authors:  Ting Zhang; Malgorzata A Garstka; Ke Li
Journal:  J Immunol Res       Date:  2017-06-15       Impact factor: 4.818

2.  Acylation-stimulating protein is a surrogate biomarker for acute myocardial infarction: Role of statins.

Authors:  Hayder M Al-Kuraishy; Ali I Al-Gareeb
Journal:  J Lab Physicians       Date:  2017 Jul-Sep
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.